Research status and advances in immunotherapy for chronic myeloid leukemia

Chronic myeloid leukemia (CML) is a malignant hematologic disorder caused by abnormal proliferation of hematopoietic stem cells. In recent years, while the application of tyrosine kinase inhibitors (TKIs) has significantly improved the prognosis of CML patients through in-depth exploration of pathog...

Celý popis

Podrobná bibliografie

Hlavní autoři:	WANG Mengmeng, MA Jingyun, XIONG Boyu, DAI Zhuowen, PAN Yueyue, WANG Qiong
Médium:	Artigo
Jazyk:	Chinês
Vydáno:	Institute of Blood Transfusion of Chinese Academy of Medical Sciences 2025-05-01
Edice:	Zhongguo shuxue zazhi
Témata:	chronic myeloid leukemia immunotherapy t cells nk cells telomeres
On-line přístup:	https://www.cjbt.cn/thesisDetails#10.13303/j.cjbt.issn.1004-549x.2025.05.022&lang=en
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!